|
KR20200143805A
|
|
Preparing method of crystalline polaprezinc using aqueous solution
|
|
KR20200136167A
|
|
New preparing method of Polaprezinc
|
|
KR20200077733A
|
|
A process for preparing 3,11-Dichloro-6-methyl -6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide
|
|
KR101724301B1
|
|
Novel crystal form I of varenicline salicylate and its preparing method
|
|
KR20160116463A
|
|
L-- III Crystalline form III of L--glyceryl phosphoryl choline and its preparation method
|
|
KR20160109736A
|
|
Process for preparing intermediate of silodosin
|
|
KR20130063521A
|
|
Preparation of crystalline form ii of glyceryl phosphoryl choline
|
|
KR20130063520A
|
|
A preparation of crystalline form i of glyceryl phosphoryl choline
|
|
KR101233138B1
|
|
A PROCESS FOR PREPARING L-α-GLYCERYL PHOSPHORYL CHOLINE
|
|
KR20130140296A
|
|
Method for preparing crystalline form iii of temocapril hydrochloride
|
|
KR20130136126A
|
|
A preparing method of chiral 1,4-thiazepin phenyl butanoate compound
|
|
KR20130101722A
|
|
A process for preparing 2-(4-formylphenyl)propionic acid by using tempo catalyst
|
|
KR20130101721A
|
|
A process for preparing 2-(4-formylphenyl)propionic acid by using carbon-based catalyst
|
|
KR20130017187A
|
|
A process for preparing allyl cyanide of high purity by using lewis acid catalyst
|
|
KR20120119468A
|
|
Resolution method of racemic 1,4-thiazepine compound
|
|
KR20120119467A
|
|
Preparation of amine compound useful for intermediate of temocapril
|
|
KR20120104780A
|
|
Crystalline form i of glyceryl phosphoryl choline and its preparing method
|
|
KR20120104781A
|
|
Crystalline form ii of glyceryl phosphoryl choline and its preparing method
|
|
KR20110066004A
|
|
Preparation of choline alfoscerate
|
|
KR20100120558A
|
|
Recrystallization process of sarpogrelate hcl
|
